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Visualization of Small
Extracanalicular Neurilemomas
By Metrizamide Cisternographic Enhancement
Arthur E. Rosenbaum, MD; Burton P. Drayer, MD; Philip J. Dubois, MD; F. Owen Black, MD
\s=b\Metrizamide (Amipaque) computer-
ized tomography cisternography (CTC)
provides a rapid, simple, and accurate
radiographic modality of intrathecal en-
hancement for detecting and morphologi-
cally characterizing cerebellopontine(CP) angle masses. The technique is of
especial value in masses < 1.5 cm that
are not detected on intravenously en-
hanced computerized tomography. Metri-
zamide CTC was used in six patients with
no CP angle mass and in four patients
with acoustic neurilemomas.
(Arch Otolaryngol 104:239-243, 1978)
The radiological query of suspectedcerebeliopontine (CP) angle
masses includes conventional and of-
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ten special diagnostic studies. Specific
types of radiological investigations
are initially based on clinical esti¬
mates of the breadth of tumor bound¬
aries. Conventional skull roentgeno¬
grams and/or tomograms usually af¬
firm the intracanalicular component
of expanding eighth-nerve masses.1
However, it is the extracanalicular
portion of acoustic neurilemomas that
determines the surgical approach.
Positive contrast cisternography with
iophendylate injection (Panto-
paque),-:i pneumoencephalography,4
and/or angiographyV!l are usually em¬
ployed in this sequence to outline the
extracanalicular extension of eighth-
nerve tumors. Larger extracanalicular
neurilemomas have been shown to be
vascular by also performing selective
external carotid arteriography.78
Cranial computerized tomography(CT),1"11 especially following intrave¬
nous enhancement, provides a rela¬
tively safe and reliable modality for
demonstrating the extracanalicular
Table 1.—Patients Suspected of Having a Cerebeliopontine Angle Mass Lesion*
Case History
Cranial Nerve
Palsy or Paralysis
Auditory and Vestibular
Testing or Patterns
R Bell's hearing loss; tin¬
nitus
R VIM, VII Retrolabyrinthine
2 R hearing loss; tinnitus R VIII Retrolabyrinthine
R trigeminal neuralgia;
hearing loss; tinnitus
R V, VII, Vili, IX,  Retrolabyrinthine
4 L trigeminal neuralgia L VIII, V Retrolabyrinthine
5 L hemlfaclal spasm Normal
L Bell's palsy; L
synklnesia
L VII Bilateral peripheral labyrinthine
7 L trigeminal neuralgia L V Normal cochlear; vestibular
tests not performed
L trigeminal neuralgia L V Retrolabyrinthine
L hemifacial spasm; L tri¬
geminal neuralgia
L V, VII Bilateral retrolabyrinthine
10 R Bell's palsy; R hemifa¬
cial spasm; R hearing
loss and tinnitus
R VII, VIM Right retrolabyrinthine
*R Indicates right; L, left.
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Table 2.—Comparison of Radiological Methods for Visualizing Clinically Suspected Masses of the Cerebeliopontine Angle*
Plain Skull
Case Roentgenograms
Polytomes Into
Auditory Canals
lophendylate
Injection
Cisternogram
Intravenously
CT Enhanced CT
Intrathecally
Enhanced CTC,
Metrizamide
Surgical
Diagnosis, Size
Enlarged R IAC Enlarged R IAC R acoustic neurilemo-
ma, 1 cm
2 Enlarged R IAC Enlarged R IAC R acoustic neurilemo-
ma, 1 cm
3 Surgical Surgical No Poor detail Recurrent R acoustic
neurilemoma, 3 cm
Normal Normal No L acoustic neurilemo¬
ma, 4 cm
? Destruction
of apex of R
petrous bone
? Destruction of apex
of R petrous bone
No Microvascular decom¬
pression; no tumor
6 Normal Normal No Microvascu
pression
lar decom-
no tumor
7 Normal Normal Microvascu
pression
lar decom-
no tumor
8 Enlarged L foramen
ovale
Enlarged L
foramen ovale
No Microvascu
pression;
lar decom-
no tumor
Normal Normal No Microvascu
pression;
ar decom-
no tumor
10 Normal Normal No Microvascu
pression
lar decom-
no tumor
*CT indicates computerized tomography; CTC, computerized tomography cisternography; IAC, internal auditory canal; +, positive; —, negative; no,
not performed; L, left; R, right.
extension of eighth-nerve neurilemo¬
mas. However, this method fails to
demonstrate small (< 1.5 cm) CP
angle masses.1- Computerized tomog¬
raphy image-reconstruction artifacts
in the CP, pontine, and interpedun-
cular cisterns are principally caused
by the very low radiodensity of air in
the mastoids and the high radioden¬
sity of the petrous bones. Intravenous
enhancement has greatly improved
the visualization of medium-sized (1.5
to 3 cm) and large (> 3 cm) neurilemo¬
mas.
Pharmaceutical and clinical re¬
search with nonionic, water-soluble,
iodinated contrast media has provided
a new agent, metrizamide (Ami-
paque), that is relatively safe for use
above the conus medullaris. After
injection into the lumbar subarach-
noid space, this contrast can be simply
and rapidly displaced from the lumbar
theca to the intracranial subarachnoid
spaces for immediate computerized
tomographic imaging. This technique,
called metrizamide CT cisternography
(CTC), appears to demonstrate all
surgically pertinent regional anatomy
affected by CP angle masses (Fig 1).
Improved presurgical planning would
be afforded by more accurate delinea¬
tion of the planes of growth of the
neoplasm. The safety and efficacy of
this method lies in using small doses
of this radiodense agent since a high
sensitivity of detection is afforded by
CT imaging. Were conventional or
even sophisticated tomographic radi¬
ography used at these doses, masses
would not be visualized. This commu¬
nication will describe the use and
value of metrizamide CTC in the
demonstration of small eighth-nerve
tumors.
METHODS
Metrizamide CTCs were performed on
ten patients suspected clinically of harbor¬
ing a CP angle mass lesion (Table 1). No
premedication was used. Lumbar puncture
was performed with image-intensified
fluoroscopy using a 22-gauge needle with
the patient prone on a myélographie tilt
table. The intrathecal placement of metriz¬
amide (usually 6 ml of 190 mg of iodine per
milliliter [1.14 gm of iodine]) was
verified by fluoroscopic screening. The
patient was placed erect for displacement
of the hyperbaric agent below the level of
the spinal needle. The needle was then
removed, the patient turned supine, and
the table tilted into the -60° (Trendelen-
burg's) position. After the patient had
remained head down for one minute, he
was returned to the —10° (modified Tren-
delenburg's) position, placed on a similarly
inclined stretcher, and transferred to the
CT scanner. The patient's body was
elevated above the head throughout scan-
ning with a right-triangular-shaped uphol¬
stered pillow in order to keep the hy-
perbaric radio-opaque medium in the
intracranial subarachnoid spaces during
scanning.
CT Technical Factors
Our institution had an EMI scanner
(Mark I) with the 160  160 matrix.
Usually the information was collected at
window width 50 and window level 28
(center) on 8-mm slices. When indicated,
4-mm slices provided more detailed infor¬
mation concerning the presence, nature,
and size of the CP angle masses; however,
there was more quantum noise owing to
the reduction in the intensity of the x-ray
beam. Recently, we have routinely ob¬
tained two contiguous pairs of 8-mm cuts
and have advanced the couch 12 mm rather
than 16 mm after obtaining the first pair
of slices. This results in a 4-mm overlap of
the more central posterior fossa slices.
Metrizamide Investigational Protocol
Each patient suspected of a CP angle
tumor underwent neuro-otologic investiga¬
tions prior to specialized radiological stud¬
ies. The investigational protocol precluded
use of metrizamide in any patient with a
history of seizures, recent neuroleptic
medication, or iodine allergy. Subsequent
to the metrizamide CTC, follow-up clinical
evaluations were made at six and 24 hours
after injection. Physiological values and
adverse symptoms were recorded for at
least 24 hours.
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RESULTS
Clinical and
Radiological Findings
The pertinent clinical observations
and the results of plain skull roent¬
genograms, internal auditory canal
tomograms, iophendylate cisternogra-
phy, and CT techniques in the ten
cases that were clinically suspected of
CP angle neoplasm are summarized in
Table 2. Preintravenously and postin-
travenously enhanced CT scans de¬
tected an abnormality in only one of
the four cases of eighth-nerve neurile-
moma that was well localized by intra-
thecal metrizamide enhancement (Fig
2 through 4).
Normal Water-Soluble CTC
Surgical confirmation of normality
was obtained in the six patients with
normal results of metrizamide CTC
studies since they underwent micro-
vascular decompression (for trigem¬
inal neuralgia or hemifacial spasm).11
In one of these six surgically verified
"normal" patients, routine and intra¬
venously enhanced CT indicated a
small "cystic" low-absorption process
in the left CP angle; however, intra-
thecal metrizamide opacification
(CTC) showed no abnormality of the
region, thereby proving that the low-
absorption process was a computer-
generated artifact.
The normal metrizamide CT cister-
nograms showed a strikingly consis¬
tent morphology of the CP angles and
adjacent cisterns (Fig 1) that could be
readily correlated with gross anatomic
and pneumoencephalographic ap¬
pearances.
Abnormal Water-Soluble CTC
Histopathologic confirmation of an
acoustic neurilemoma was obtained in
the four patients with abnormal
results of metrizamide CTC studies
(Table 2). Compartmental abnormali¬
ties that suggest a small (< 1.5 cm)
CP angle space-taking lesion include
the following: (1) subarachnoid space
abnormalities, including (a) filling
defect, discontinuity, deformity, or
obliteration of the CP angle cistern(Fig 2); (ft) an enlargement of the
ambient cistern adjacent to the mass(Fig 3); or (c) a subarachnoid metri¬
zamide coating of the medial surface
Fig 1.—Normal axial plane computerized tomography (CT) scans of cerebeliopontine(CP) and adjacent sites of common growth of eighth-nerve neurilemomas. Three upper
slices were made with common technique (50 window width, window level 28 [center]).
Lower three slices are of same planes; however, window width is broader (100) and
window level is centered between 55 and 75.
A, Metrizamide in CP angle cisterns are not well separated from adjacent petrous bone(top). Choosing more suitable level for morphology in question (bottom) differentiates
metrizamide-filled CP angle cistern (arrowheads) from absorption density of petrous
bone.
B, Computerized tomography slice 8 mm more superior. Top, Metrizamide in subarach¬
noid space opacifies pons (P) on its anterior and lateral surfaces. Contiguity with inferior
portion of suprasellar cistern is well shown. Bottom, Note basilar artery (arrow) within
metrizamide-filled cistern anterior to pons and higher density of more anteriorly situated
dorsum sellae.
C, Slice 8 mm more superior than B. Top, Midbrain plane shows full extent of
subarachnoid cisterns surrounding this structure. Note superior portion of suprasellar
cistern that contains optic chiasm (central filling defect). Bottom, Broader and higher CT
windows show to better advantage quadrigeminal cistern encompassing tectum (open
arrow). Moreover, full breadth of optic chiasm is now visualized (closed arrows).
of the mass confirming its extra-axial
location; (2) flattening of the lateral
margins of the fourth ventricle (Fig
3). (Larger tumors would result in
rotation or midline displacement, as
shown on pneumoencephalography);
and (3) rotation or angulation of the
brainstem about the CP angle mass.
Other criteria include an improved
capacity for posterior fossa definition
when residual iophendylate obscures
regional structures and causes "high
density" spray artifacts (Fig 4), and
abnormalities of CSF dynamics.
Adverse Reactions
When present, these were all tran¬
sient and of minimal to moderate
severity. Any reactions occurred after
a four- to six-hour lag of well-being
and lasted no longer than 24 hours.
The side effects included headache
(5/10), nausea (5/10), vomiting (1/10),
and subtle perceptual aberrations (1/
10). Three patients were totally free
of any adverse reaction. When the
observers compared metrizamide CTC
with pneumoencephalography for vi¬
sualizing the posterior fossa subarach¬
noid spaces (and ventricular system),
they believed the morbidity of metri¬
zamide CTC to be substantially less.
Moreover, since the CT definition of
the process seemed so complete, no
additional specialized studies were
usually necessitated prior to surgery.
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Fig 2.—Eighth-nerve tumor (1 cm) of case 1. Left, Intravenous enhancement. Opacifica-
tion of cerebral vessels is so satisfactory that middle cerebral trunks (right arrow, M) and
the pericallosal arteries (PC) are well visualized. No tumoral enhancement is seen. Right,
Intrathecal enhancement with metrizamide. Cerebral peduncles are asymmetric as
defined by contrast agent in interpeduncular (I) and ambient (A) cisterns. Right ambient
cistern is much widened owing to mass exiting from porus acusticus and further
separating pons from petrous bone and cerebellum. Mass is sufficiently large and
posterior in its growth to result in subtle flattening and meager rotation of right side of
fourth ventricle (arrow) as viewed in axial plane.
Fig 3.—Small eighth-nerve tumor (1 cm) of case 2. A, Intravascular enhancement. Small
pea-sized mass (arrow) is seen adjacent to laterally convex bony defect of porus
acusticus. B, Intrathecal enhancement. Intravenously enhanced cerebeliopontine angle
density of A is seen as extra-axial filling defect that is surrounded by metrizamide(arrowheads). C, Similar plane as B, but imaged with 4-mm rather than 8-mm collimator
to improve precision of localization of mass (arrowheads).
COMMENT
Animal experiments have con¬
firmed the relatively low toxicity of
metrizamide in the intracranial sub¬
arachnoid spaces when it is compared
with iothalamate meglumine injection(Conray) and iocarmate meglumine
(Dimer-X).14 In baboons, following the
suboccipital i tracisternal introduc¬
tion of metrizamide, toxic side effects
were found to be directly dose depen¬
dent,'5 which militates against the
very safe conventional radiographie
demonstration of the posterior fossa
subarachnoid spaces. Since CT is far
more sensitive than conventional ra¬
diography in detecting subtle absorp¬
tion differences, the adult metriz¬
amide dose described here (1.14 gm of
iodine) is sufficient to obtain precise
representation of the basal subarach¬
noid cisterns and the fourth ventricle.
With this low-dose technique and
immediate intracranial placement of
the lumbar-injected metrizamide, the
majority of side effects have been
mild, no seizures have occurred, and
no anticonvulsant prophylaxis was
necessary.
Metrizamide CTC18"18 provides a
relatively low morbidity, highly
graphic technique for visualizing the
basal cisterns of the region of the CP
angle, porus acusticus, and internal
auditory canal. Its value can be
related to other techniques.
Fig 4.—Now recurrent eighth-nerve tumor(3 cm) previously localized by ¡ophendy-
late injection (P) and operated on via
posterior occipital approach. Intravenous¬
ly enhanced computerized tomography
scan was nondiagnostic owing to obscu¬
ration by surgical clips and iophendylate.
A, Cerebral peduncles of midbrain are
mildly asymmetric and fourth ventricle (IV)
is slightly flattened from its right side(reader's right side also). Low-absorption
region posterior to right cerebeliopontine(CP) angle represents cerebellar infarction
of tissue. Residual iophendylate is seen in
right Sylvian fissure (P).
B, Slice at plane of pons shows amputated
and flared midanterior portion of right
ambient cistern. Metallic clip (C) provides
some obscuration of this region.
C, Same slice as B, but assessed by
selecting only specific coefficient of atten¬
uation (EMI + 36) rather than usual wider
window. This not only shows CP angle
filling defect well (arrows), but minimizes
spray effects of metallic clip.
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Fig 5.—Brainstem surface and metriz¬
amide opacified cerebeliopontine angles
using new EMI body scanner (CT5005).
Metrizamide can be seen in juxtaposition
to internal auditory canals.
Iophendylate in small quantities
can define small lesions well; however,
since the magnitude of CP angle
involvement cannot be predicted from
plain films or tomograms when a
medium- or larger-sized tumor is pres¬
ent, iophendylate cisternography can
end in an uncontrolled, rapid, irrevers¬
ible spill of the agent into the middle
cranial fossa. Moreover, arachnoiditis,
whether it is clinically evident or not,
is a consequence of residual iophendy¬
late. In addition, subsequent CT scans
for tumor recurrence are more diffi¬
cult to evaluate in the presence of
residual iophendylate.
Pneumoencephalography with plu-
ridirectional tomography is an ele¬
gant, but almost invariably morbid
technique. Better definition usually
relates to larger quantities of gas in
the subarachnoid space when both CP
angle cisterns are examined simulta¬
neously. Vertebral angiography usual¬
ly defines the presence, but not the
character, of a CP angle mass. The
capsule and definitive angioarchitec-
tural demonstration of the mass is
usually derived from selective eathe-
terization of the ascending pharyn-
geal or occipital branches of the
external carotid artery.7'' In the
awake patient, this procedure may be
quite painful and is most helpful in
assessing larger lesions. From current
observations, it is believed that CT
scanning with intravenous enhance-
ment is likely to demonstrate only CP
angle tumors larger than 1.5 cm. Since
the clinical thrust in recent years is to
detect small, "early" tumors, metriz¬
amide CTC provides an important
new modality to augment the otologie
methods.
When otologie and preliminary ra¬
diological examinations strongly sug¬
gest the presence of an eighth-nerve
neurilemoma or other tumor in the CP
angle, intravenously enhanced CT is
very likely to show medium- and
larger -sized masses. However, when
intravenously enhanced CT detects no
abnormality, metrizamide CTC
appears to be the definitive study,
thereby obviating the need for addi¬
tional radiological examinations.
The definition already offered by
newer scanners (Fig 5) strongly
suggests that metrizamide can be
seen in the region of the porus acus¬
ticus and is likely to be visible within
the internal auditory canal; thus, CT
can show the bony morphology of the
internal canals satisfactorily and me¬
trizamide CTC can show the intraca-
nalicular subarachnoid space. Thus,
the role of iophendylate injection
cisternography in the future is ques¬
tioned since this simple intrathecal
examination of metrizamide should
excellently define both the extraca¬
nalicular and intracanalicular pres¬
ence of acoustic nerve neoplasms.
Coronal- and sagittal-plane computer
sections are also becoming more
broadly available if there is the need
for further confirmation of very small
masses.
Conventional radiography or con¬
ventional tomography can be used to
image metrizamide placed in the
internal auditory canals or CP angle
cisterns. However, without the high
sensitivity of CT (approximately 100-
fold that of radiography), larger doses
and much more severe side effects can
occur (eg, seizures). Computerized
tomography imaging is therefore
stressed.
Metrizamide was provided by Nygaard & Co,
Oslo, and by Sterling-Winthrop Research Insti¬
tute, Rensselaer, NY.
Nonproprietary Name
and Trademark of Drug
Metrizamide—Amipaque.
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